Logo
SYSTEMIC SCLERODERMA TREATMENT MARKET ANALYSIS
  2. / Market Insights
  3. Systemic Scleroderma Treatment Market Analysis
all report title image

SYSTEMIC SCLERODERMA TREATMENT MARKET ANALYSIS

Systemic Scleroderma Treatment Market, By Drug Class (Immunosuppressant, Phosphodiesterase 5 inhibitors - PHA, Endothelin Receptor Antagonists, Calcium Channel Blockers, Prostacyclin Analogues, and Others), By Type (Limited Systemic Sclerosis, Diffused Systemic Sclerosis, and Sine Sclerosis), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Nov 2024
  • Code : CMI4641
  • Pages :164
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Systemic Scleroderma Treatment Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • GSK plc
  • Certa Therapeutics
  • Aisa Pharma, Inc.
  • Corbus Pharmaceuticals
  • AbbVie, Inc.
  • Biogen
  • Novartis AG
  • AstraZeneca
  • Celgen Corporation
  • ONO PHARMACEUTICAL CO., LTD.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH.
  • MediciNova, Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Systemic Scleroderma Treatment Market to Surpass US$ 2.39 Bn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.